,On 4 January 2026, the National Medical Products Administration (NMPA) issued an announcement detailing the third dynamic adjustment to the Catalogue of Used Cosmetic Ingredients (also known as the Inventory of Existing Cosmetic Ingredients in China, IECIC). The updates, in accordance with prior NMPA guidelines on catalogue management, aim to refine the regulatory framework for cosmetic ingredients by incorporating previously categorised used substances and standardising nomenclature to ensure clarity, safety, and industry compliance. Key focused content includes additions to Catalogue I: three ingredients previously excluded from new cosmetic ingredient filings due to their classification as existing used ingredients have now been formally included after review. These are noted in the remarks for transparency. Individual ingredient names and changes: 1. Black Ginseng Extract: Included in Catalogue I; note clarifies prior cancellation of new ingredient filing. 2. Hydrolysed Zinc Hyaluronate: Included in Catalogue I; note clarifies prior cancellation of new ingredient filing. 3. Galactomannan: Included in Catalogue I; note clarifies prior cancellation of new ingredient filing. Additionally, Chinese names, INCI names, or English names for relevant ingredients have been normalised, and associated notes revised. No specific test methods are mentioned for these ingredients. Analysis of attachments: The original page contains no attachments, downloadable files, or tables; updates are described textually without supplementary documents.
Consumer News Region